Skip to main content
Clinical Trials/NCT00603681
NCT00603681
Completed
Phase 4

Non-Inferiority Study; Comparison of Polyethylene Glycol Solution With and Without Electrolytes for Treatment of Chronic Constipation in Elderly Institutionalised Patients: a Double-Blind, Randomised, Parallel-Group, Multicentre Study

Orion Corporation, Orion Pharma10 sites in 1 country67 target enrollmentJanuary 2008

Overview

Phase
Phase 4
Intervention
Polyethylene glycol 4000
Conditions
Constipation
Sponsor
Orion Corporation, Orion Pharma
Enrollment
67
Locations
10
Primary Endpoint
Stool frequency
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The aim of the study is to show that new polyethylene glycol (PEG) solution without electrolytes is as effective in the treatment of constipation as PEG solution with electrolytes in the elderly institutionalized people. Also, the tolerability and the safety of the study drug will be examined.

Detailed Description

Constipation is a major problem in elderly institutionalised patients. Non-pharmacological treatments are proposed as primary management of constipation, but institutionalised patients are not likely to be able to increase either the intake of dietary fibre or fluid and their physical activity is low. The latest agent widely used for the treatment of constipation is polyethylene glycol (PEG). PEG is classified into the group of osmotic laxatives. It is minimally absorbed from the gastrointestinal tract and not metabolised by colonic bacteria. Most of the PEG products at the market contain electrolytes and have a salty and unpleasant taste which may affect the compliance of using them. A PEG solution without electrolytes has been developed and used for some years in various countries. Now we will compare the efficacy and safety of PEG solutions with or without electrolytes and their acceptability in the use for constipation in institutionalised patients.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
July 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Isotonic PEG treatment for constipation at the stable dose for at least 2 weeks before the run-in period

Exclusion Criteria

  • Other medical treatment for constipation than isotonic PEG or plantago ovata seeds
  • Severe dementia

Arms & Interventions

T

Test product

Intervention: Polyethylene glycol 4000

C

Reference product

Intervention: Polyethylene glycol 4000 with electrolytes

Outcomes

Primary Outcomes

Stool frequency

Time Frame: week 4

Secondary Outcomes

  • Stool frequency(Week 2)
  • Stool straining(Weeks 2 and 4)
  • Stool consistency(Weeks 2 and 4)

Study Sites (10)

Loading locations...

Similar Trials